Turner was elected to serve Texas' 18th Congressional in November 2024. Turner was diagnosed with Osteosarcoma, a form of bone cancer, in 2022. HOUSTON - Congressman and former Houston Mayor ...

“We know one of the US government’s stated priorities is to treat deadly childhood cancers, and we believe that OST-HER2 for osteosarcoma aligns well with that mission.” Regulatory Timelines ...

Routine Clinical Liquid Biopsy Testing for Solid Tumors Delivers the Promise of Minimally Invasive Detection of Genomic Variants With a Faster Turnaround Time Osteosarcoma (OS) is the most prevalent ...

Biosciences, announced that its collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an ...

OST-HER2 is an immunotherapy for osteosarcoma using a HER2 bioengineered form of the bacteria Listeria monocytogenes to trigger a strong immune response against cancer cells expressing HER2.

The company’s canine osteosarcoma program has identified potential biomarkers that may predict treatment response in humans. While the stock has experienced a significant decline of 62% year-to ...

OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today reported full-year 2024 financial ...

Biosciences’ collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an exploratory clinical ...

OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today provided a regulatory update for its ...